Skip to main content
. 2015 Oct 24;15:787. doi: 10.1186/s12885-015-1762-3

Fig. 3.

Fig. 3

Direct average monthly costs by patient cohort and line of treatment. Costs in cohort A 1st line (HT) were significantly lower compared with costs in cohort A 2nd line (chemotherapy) and cohort C (any therapy; p < 0.001 for both comparisons, Mann-Whitney U test). Abbreviation: HT, hormone therapy